Linnea Acquisition Fuels Vivalto Partners' Botanical Expansion
Deal News | Apr 03, 2025 | Legal Community Swiss
In an important expansion within the healthcare sector, Vivalto Partners, an independent management company based in Paris, has successfully acquired 100% ownership of Linnea, a Swiss pharmaceutical manufacturer noted for its production of botanical ingredients and semi-synthetic APIs. This strategic acquisition, facilitated as a primary buyout, includes significant investment from Linnea's management team, allowing the Swiss company to further develop and innovate in plant-based therapeutics. Renowned law firm Lenz & Staehelin played a crucial advisory role by guiding Vivalto Partners on Swiss tax matters related to the acquisition. The transaction highlights Vivalto's commitment to expanding its portfolio in specialized healthcare segments, particularly in botanical therapeutics.
Sectors
- Healthcare
- Pharmaceuticals
- Private Equity
Geography
- Switzerland – Linnea, the target company, is based in Switzerland.
- France – Vivalto Partners, the acquiring company, is headquartered in Paris, France.
Industry
- Healthcare – Vivalto Partners focuses on investments in the healthcare sector, and Linnea's business involves botanical therapeutics.
- Pharmaceuticals – Linnea is a pharmaceutical company manufacturing botanical ingredients and semi-synthetic APIs.
- Private Equity – The acquisition by Vivalto Partners, a private equity firm, highlights the role of financial investments in strategic corporate growth.
Financials
- Not Disclosed – The financial terms of the acquisition transaction were not disclosed.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Vivalto Partners | Acquirer | Company | An independent management company specializing in healthcare sector investments, based in Paris. |
| Linnea | Target Company | Company | A Swiss pharmaceutical manufacturer known for its botanical ingredients and semi-synthetic APIs. |
| Lenz & Staehelin | Legal Advisor | Company | A law firm advising on Swiss tax matters related to the acquisition. |
| Linnea's Management Team | Investor | Company | Investment team supporting the development of Linnea in botanical therapeutics. |